Catalyst Pharmaceuticals Files 8-K
Ticker: CPRX · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
Related Tickers: CPRX
TL;DR
Catalyst Pharma filed an 8-K on June 1st, details to follow.
AI Summary
Catalyst Pharmaceuticals, Inc. filed an 8-K on June 2, 2025, reporting an event that occurred on June 1, 2025. The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as key information. No specific financial figures or new material events were detailed in the provided text.
Why It Matters
This filing serves as an official notification to the SEC and investors about significant corporate events or financial updates. The lack of specific details in the provided excerpt means further review of the full filing is needed to understand the implications.
Risk Assessment
Risk Level: low — The filing itself is a routine disclosure and does not inherently present new risks, but the content of the full report may contain material information.
Key Players & Entities
- CATALYST PHARMACEUTICALS, INC. (company) — Registrant
- June 1, 2025 (date) — Earliest event date
- June 2, 2025 (date) — Report date
FAQ
What specific 'Other Events' are being reported by Catalyst Pharmaceuticals, Inc.?
The provided text does not specify the 'Other Events' beyond listing it as an item information category.
What is the significance of the 'Financial Statements and Exhibits' being listed?
This indicates that the filing includes financial information or exhibits, which could be related to recent performance or other corporate actions.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 1, 2025.
What is the principal executive office address for Catalyst Pharmaceuticals, Inc.?
The address is 355 Alhambra Circle, Suite 801, Coral Gables, Florida, 33134.
What is the SEC file number for Catalyst Pharmaceuticals, Inc.?
The SEC file number is 001-33057.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding CATALYST PHARMACEUTICALS, INC. (CPRX).